Analysts think ATRA stock price could increase by 38%
Dec 25, 2024, 12:26 PM
-48.01%
What does ATRA do
Atara Biotherapeutics, headquartered in Thousand Oaks, California, is a biotechnology company specializing in allogeneic T-cell immunotherapy, with products like Ebvallo and ATA3219 in various development stages. The company went public on October 16, 2014, and employs 173 staff.
5 analysts think ATRA stock price will increase by 37.73%. The current median analyst target is $18.36 compared to a current stock price of $13.33. The lowest analysts target is $10.10 and the highest analyst target is $22.05.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.